pharmacy benefit manager

Settlements and kickbacks and corporate integrity agreements, oh my (to the tune of "lions and tigers and bears, oh my")

To quote the BusinessWeek version of the story:

A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry.

We posted a number of times about questionable practices Eli Lilly used to market its atypical anti-psychotic drug Zyprexa (olanzapine).

A post from 2007, with links backward, is here, and our most recent post is here.

The company remains entangled in litigation over its marketing of this drug.

National pharmacy benefit management company Medco will significantly improve access to its services for limited English proficient members in 2009, the U.S.

Department of Health and Human Services (HHS) announced today.

Today we learned that President Obama has announced his new picks for Secretary of Health and Human Services and for Director of the White House Office for Health Reform.

The choice of Nancy-Ann DeParle for the latter position raises some issues. The NY Times provides some background: